Search CommunityWalk:


ImQuest Life Sciences

7340 Executive Way, Suite R
Frederick, MD 21704, USA

Category: Pharmaceutical

Used in the following map:

Maryland Biotech Industry Map

ImQuest Life Sciences is a drug discovery and development company focused on the strategy of developing a proprietary portfolio of therapeutic agents to target infectious disease and cancer.

ImQuest Life Sciences' pipeline includes: exclusive licenses to highly potent compounds for the treatment of Human Immunodeficiency Virus (HIV), Hepatitis B and Hepatitis C Virus (HBV, HCV), Influenza, including Drug- and Antibiotic-Resistant Microorganisms, and Cancer. The company focuses on the following drug development programs: therapies for the treatment of HIV; topical microbicides for the prevention of transmission of HIV and other sexually transmitted infections; therapies for the treatment of HBV and HCV; and therapies for the treatment of cancer. Its product pipeline includes: infectious disease- HBV lead discovery and IQP-0410 for HIV; anti-cancer agents- IQP-0303 for leukemia and IQP-0304 for prostate cancer; and topical microbicides- IQP-0528, IQP-0831, and IQP-1187.

ImQuest Life Sciences has a drug development alliance with Samjin Pharmaceutical Co. Ltd. The company also forms strategic drug development alliances with individuals, academic institutions, biotechnology companies and pharmaceutical companies which possess novel drug development strategies and technology. It has collaborations with Arisyn Therapeutics, Inc., Aethlon Medical, Inc., International Partnership for Microbicides, Inc., Isis Pharmaceuticals Inc, etc.